Moreover, combining G-CSF with meloxicam, an anti-inflammatory cyclooxygenase two inhibitor, resulted in similar anti-inflammatory and antiapoptotic effects in the rAION as mentioned above, with the additional effect of decreasing GCS-F-associated leukocytosis [42]. The gene discussed is CSF3; the disease is Increased total leukocyte count.